235 related articles for article (PubMed ID: 18320916)
1. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting.
Lee-Wong M; Chou V; Ogawa Y
Ann Allergy Asthma Immunol; 2008 Feb; 100(2):146-52. PubMed ID: 18320916
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
LaForce C; Prenner BM; Andriano K; Lavecchia C; Yegen U
J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.
Najafizadeh K; Sohrab Pour H; Ghadyanee M; Shiehmorteza M; Jamali M; Majdzadeh S
Emerg Med J; 2007 May; 24(5):317-21. PubMed ID: 17452695
[TBL] [Abstract][Full Text] [Related]
5. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
Bensch G; Lapidus RJ; Levine BE; Lumry W; Yegen U; Kiselev P; Della Cioppa G
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):19-27. PubMed ID: 11206232
[TBL] [Abstract][Full Text] [Related]
6. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
[TBL] [Abstract][Full Text] [Related]
7. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
8. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
Pleskow W; LaForce CF; Yegen U; Matos D; Della Cioppa G
J Asthma; 2003; 40(5):505-14. PubMed ID: 14529100
[TBL] [Abstract][Full Text] [Related]
9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
11. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
12. Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations.
Rodriguez E; Vera V; Perez-Puigbo A; Capriles-Hulett A; Ferro S; Manrique J; Abate J
Allergol Immunopathol (Madr); 2008; 36(4):196-200. PubMed ID: 18928685
[TBL] [Abstract][Full Text] [Related]
13. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
[TBL] [Abstract][Full Text] [Related]
14. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A
Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
16. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
17. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
Wallin A; Sandström T; Rosenhall L; Melander B
Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
Watanasomsiri A; Phipatanakul W
Ann Allergy Asthma Immunol; 2006 May; 96(5):701-6. PubMed ID: 16729783
[TBL] [Abstract][Full Text] [Related]
19. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
Blais L; Beauchesne MF; Forget A
Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647
[TBL] [Abstract][Full Text] [Related]
20. A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting.
Bussamra MH; Stelmach R; Rodrigues JC; Cukier A
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):248-53. PubMed ID: 19788023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]